Prosight Management as of June 30, 2018
Portfolio Holdings for Prosight Management
Prosight Management holds 31 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CIGNA Corporation | 9.6 | $13M | 77k | 169.95 | |
| Macrogenics (MGNX) | 9.4 | $13M | 619k | 20.65 | |
| Allergan | 8.8 | $12M | 72k | 166.72 | |
| Teligent | 8.4 | $12M | 3.3M | 3.46 | |
| Pieris Pharmaceuticals (PIRS) | 5.0 | $6.9M | 1.4M | 5.07 | |
| athenahealth | 4.8 | $6.6M | 41k | 159.13 | |
| Arena Pharmaceuticals | 4.5 | $6.1M | 140k | 43.60 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 4.4 | $6.0M | 1.2M | 5.20 | |
| Iovance Biotherapeutics (IOVA) | 4.1 | $5.6M | 440k | 12.80 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $5.5M | 58k | 94.20 | |
| Shire | 4.0 | $5.4M | 32k | 168.81 | |
| Eiger Biopharmaceuticals | 3.9 | $5.3M | 438k | 12.20 | |
| Sierra Oncology | 3.9 | $5.3M | 1.8M | 2.96 | |
| Kura Oncology (KURA) | 3.8 | $5.2M | 288k | 18.20 | |
| Intec Pharma | 3.6 | $5.0M | 1.1M | 4.40 | |
| Achaogen | 2.4 | $3.2M | 375k | 8.66 | |
| Mylan Nv | 2.1 | $2.9M | 81k | 36.14 | |
| Reata Pharmaceuticals Inc Cl A | 2.1 | $2.9M | 83k | 34.97 | |
| Assembly Biosciences | 1.9 | $2.6M | 65k | 39.20 | |
| Sabra Health Care REIT (SBRA) | 1.6 | $2.1M | 99k | 21.73 | |
| Esperion Therapeutics (ESPR) | 1.4 | $1.9M | 49k | 39.18 | |
| Paratek Pharmaceuticals | 1.1 | $1.5M | 145k | 10.20 | |
| Nabriva Therapeutics | 1.1 | $1.5M | 421k | 3.48 | |
| Centene Corporation (CNC) | 1.0 | $1.3M | 11k | 123.22 | |
| Aquinox Pharmaceuticals | 0.8 | $1.1M | 401k | 2.65 | |
| Noveliontherapeuti.. | 0.5 | $716k | 195k | 3.68 | |
| Kezar Life Sciences (KZR) | 0.5 | $721k | 42k | 17.29 | |
| Civitas Solutions | 0.4 | $568k | 35k | 16.39 | |
| Cellectis S A (CLLS) | 0.4 | $548k | 19k | 28.26 | |
| AVEO Pharmaceuticals | 0.2 | $337k | 149k | 2.26 | |
| Aveo Pharmaceuticals | 0.1 | $158k | 70k | 2.25 |
